Longeveron® Co-Founder and Chief Science Officer Dr. Joshua

Laromestrocel is a proprietary, scalable, allogeneic cellular therapy being evaluated to improve the clinical outcomes of children with HLHS Full enrollment achieved for pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLHS, a rare pediatric disease and orphan-designated indication ELPIS II top-line trial results are anticipated in the … Read more

Miley Cyrus’s Radio Record Has Been Matched — And Might Soon Be Beaten

Alex Warren’s “Ordinary” spends its eighteenth week at No. 1 on Radio Songs, tying Miley Cyrus and the Goo Goo Dolls for the third-longest reign in chart history. TONSBERG, NORWAY – JULY 10: Alex Warren performs on stage during Slottsfjell festival at Slottsfjellet on July 10, 2025 in Tonsberg, Norway. (Photo by Anne-Marie Forker/Redferns) Redferns … Read more

Farmers & Merchants Bancorp, Inc. Reports 2025

ARCHBOLD, Ohio, Oct. 27, 2025 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) today reported financial results for the 2025 third quarter and year-to-date ended September 30, 2025 on a consolidated basis. 2025 Third Quarter Financial and Operating Highlights(at September 30, 2025 and on a year-over-year basis unless noted) 90 consecutive quarters of … Read more

Advent Technologies Commissions Arxicon as Master Planner

LIVERMORE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) — Advent Technologies Holdings, Inc. (NASDAQ: ADN), through its wholly owned subsidiary Advent Technologies S.A., is pleased to announce its official collaboration with Arxicon, a leading Greek engineering and project management firm, for the development of its master plan for the RHyno Project. The RHyno Project officially commenced … Read more

Neinor Homes completes €140mn ABB, eyeing further growth

MADRID, Oct. 27, 2025 (GLOBE NEWSWIRE) — Neinor successfully raised €140mn through an accelerated bookbuild offering (ABB) through the issuance of 8,900,190 new shares at €15.73/sh. Orion, Neinor’s largest shareholder, subscribed €100mn, reinforcing its long-term commitment to the company and confidence on its equity efficient growth strategy. An additional €40mn was subscribed by existing shareholders … Read more

Embassy Bancorp, Inc. Announces Stock Repurchase Program

BETHLEHEM, Pa., Oct. 27, 2025 (GLOBE NEWSWIRE) — Embassy Bancorp, Inc. (OTCQX: EMYB) (the “Company”), the parent company of Embassy Bank For the Lehigh Valley (the “Bank”), announces that the Board of Directors has authorized the adoption of a stock repurchase program for up to $5 million of its outstanding common stock. The stock repurchase program … Read more

Liquidia Corporation to Report Third Quarter 2025 Financial

MORRISVILLE, N.C., Oct. 27, 2025 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its third quarter 2025 financial results on Monday, November 3, 2025. The company will host a webcast at 8:30 a.m. Eastern Time to discuss its … Read more